Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Ann Plast Surg. 2015 Jan;74(1):22–25. doi: 10.1097/SAP.0b013e31828d7285

Table 1.

Patient demographics (n=50)

Demographic n (range or %)
Mean Age at Diagnosis (years) 51.7 (28-78)
Mean BMI 32.9 (18-63)
Mean UELI 103.6 (73.4-143.3)
Lymphedema stage
    Stage 1 lymphedema 16 (32%)
    Stage 2 lymphedema 34 (68%)
Axillary lymph node evaluation
    ALND 39 (78%)
        Mean number of ALN 22 (10-49)
        Median number of ALN 20
        Mode number of ALN 13, 22
    SNL biopsy 11 (22%)
        Mean number of SLN 6 (0-17)
        Median number of SLN 3
        Mode number of SLN 2, 3, 13
Radiation 32 (64%)
Chemotherapy 40 (80%)
    Adjuvant 24 (48%)
    Neoadjuvant 16 (32%)
Immediate Reconstruction 3 (6%)
Complication 12 (24%)
Smoking
    Never Smoked 26 (52%)
    Ever Smoked 24 (48%)
Comorbidities
    Hypertension 17 (34%)
    Dyslipidemia 9 (18%)
    Diabetes 4 (8%)

BMI indicated body mass index; UELI upper extremity lymphedema index; ALND axillary lymph node dissection; SNL sentinel lymph node